CUMBERLAND, Rhode Island, October 21 /PRNewswire/ --

Neurotech Pharmaceuticals, Inc., a privately-held biotechnology company focused on the development of sight-saving therapeutics for chronic retinal diseases, announced today the opening of its new 27,000 square-foot GMP manufacturing facility in Cumberland, Rhode Island.

With support from the Rhode Island Economic Development Corporation (RIEDC) and its financing programs, Rhode Island Industrial Facilities Corporation (RIIFC) and Rhode Island Industrial-Recreational Building Authority (IRBA), Neurotech was approved for a US$4 million financing to help pay for the cost of equipping this facility.

READING, England, October 21 /PRNewswire/ --

- Company Receives 'Best in Business' Accolade for Innovation and Creativity in Carrier Ethernet Implementation

Verizon Business has been awarded the 2008 Best in Business European Carrier Ethernet Service Provider of the Year Award from the Metro Ethernet Forum (MEF). Verizon Business won on the strength of its industry leadership, innovation and creativity in the development and implementation of carrier Ethernet solutions.

PARIS, October 20 /PRNewswire/ -- Providing a framework for Body Area Networks (BAN), defining a reliable communication protocol, optimizing BAN technologies and enhancing energy efficiency of network components are the major stakes of ANR BANET (Body Area Networks and Technologies) project, which has gathered 9 French industrial and academic partners. This scientific project has been leaded by CEA-Leti and subsidized by Agence Nationale de la Recherche (ANR, National Research Agency) for a 30 months period. It aims at defining precise frameworks to design optimised wireless communication systems, both more efficient and miniaturised. These body area networks target a wide applications range, in the consumer electronics, medical and sport fields.

SAN FRANCISCO and DUBLIN, Ireland, October 21 /PRNewswire/ --

- Players Work Together as Nations to Create the Strongest Economy

BERLIN, October 21 /PRNewswire/ --

- Global Report Launch: Energy [R]evolution: Global Sustainable Energy Outlook

Dear Sir or Madam,

DETROIT, October 21 /PRNewswire/ --

LONDON, October 20 /PRNewswire/ --

United Business Media (UBM) announces that Adrian Barrick is appointed to the position of CEO of its Built Environment division.

CAMBRIDGE, Massachusetts, October 20 /PRNewswire/ --

- Abt Associates to Lead Group of Firms to Strengthen Governance and Sustainable Health Reform

MCKINNEY, Texas, October 20 /PRNewswire/ --

Torchmark Corporation (NYSE: TMK) will release Third Quarter 2008 earnings after the market closes on Wednesday, October 22, 2008. In conjunction with Torchmark's Third Quarter 2008 Earnings Release, you are invited to listen to a conference call that will be broadcast live over the Internet on Thursday, October 23, 2008 at 11:00 a.m. Eastern. At that time a copy of the Company's Q3-2008 earnings press release and any other financial and statistical information about the quarter will be available on the Company's website at www.torchmarkcorp.com on the Investor Relations page.

PRINCETON, New Jersey, October 21 /PRNewswire/ --

-Laureate to Manufacture Tolerx's TRX518 Antibody

Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced that it has entered into a cGMP contract manufacturing agreement with Tolerx, Inc., a biopharmaceutical company engaged in the discovery and development of novel therapies for the treatment of immune-mediated diseases. Under the agreement, Laureate will produce Tolerx's humanized anti-GITR antibody known as TRX518, which is currently in development for cancer and chronic viral indications. Details of the agreement were not disclosed.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080131/NETH020LOGO)